| scholarly article | Q13442814 |
| P50 | author | Claudio Brancolini | Q56697346 |
| P2093 | author name string | Harish Potu | |
| Andrea Sgorbissa | |||
| Ivana Manini | |||
| Andrea Tomasella | |||
| P2860 | cites work | Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis | Q24300558 |
| The receptor for the cytotoxic ligand TRAIL | Q24310481 | ||
| TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. | Q24314730 | ||
| Inhibition of death receptor signals by cellular FLIP | Q24316446 | ||
| UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity | Q24337310 | ||
| UBP43 (USP18) specifically removes ISG15 from conjugated proteins | Q27863712 | ||
| An antagonist decoy receptor and a death domain-containing receptor for TRAIL | Q28245153 | ||
| Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL | Q28250747 | ||
| Interferons at age 50: past, current and future impact on biomedicine | Q28259312 | ||
| Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis | Q28646425 | ||
| Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis. | Q33257957 | ||
| Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells | Q33564264 | ||
| PLANdbAffy: probe-level annotation database for Affymetrix expression microarrays | Q33600942 | ||
| Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. | Q34006269 | ||
| Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway | Q34786865 | ||
| On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics | Q35853714 | ||
| Regulation in the targeting of TRAIL receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells | Q36028494 | ||
| Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells | Q36339240 | ||
| Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer | Q37644600 | ||
| Sensitization of (colon) cancer cells to death receptor related therapies: a report from the FP6-ONCODEATH research consortium | Q37992502 | ||
| Regulation of the human TRAIL gene. | Q38034651 | ||
| IFNs, ISGylation and cancer: Cui prodest? | Q38036017 | ||
| Type I IFNs signaling and apoptosis resistance in glioblastoma cells. | Q39486541 | ||
| Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses | Q39519488 | ||
| Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosis | Q39752787 | ||
| Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system | Q39779474 | ||
| Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. | Q40105431 | ||
| Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response | Q40118478 | ||
| The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells | Q40131236 | ||
| X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells | Q40559201 | ||
| Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL. | Q42523097 | ||
| Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs | Q42944061 | ||
| Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis. | Q43961658 | ||
| TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. | Q44482351 | ||
| The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells | Q44539646 | ||
| Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL. | Q53591297 | ||
| Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. | Q55473556 | ||
| Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells | Q73405489 | ||
| IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis | Q74410110 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1158-1166 | |
| P577 | publication date | 2013-09-19 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | The DeISGylase USP18 limits TRAIL-induced apoptosis through the regulation of TRAIL levels: Cellular levels of TRAIL influences responsiveness to TRAIL-induced apoptosis | |
| P478 | volume | 14 |
| Q50045539 | CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages. |
| Q46359145 | Deubiquitinase Usp18 prevents cellular apoptosis from oxidative stress in liver cells |
| Q99591319 | Emerging Roles of USP18: From Biology to Pathophysiology |
| Q49990366 | Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target |
| Q41925201 | Long-term photoreceptor rescue in two rodent models of retinitis pigmentosa by adeno-associated virus delivery of Stanniocalcin-1. |
| Q38997388 | Multiple functions of USP18. |
| Q92219042 | The Ubiquitin-Specific Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity |
| Q59329027 | USP18 - a multifunctional component in the interferon response |
| Q35654199 | USP18 Sensitivity of Peptide Transporters PEPT1 and PEPT2. |
Search more.